Cargando…
Fluticasone impact on airway dendritic cells in smokers: a randomized controlled trial
BACKGROUND: Myeloid Dendritic cells are key drivers of inflammation in smoke-related lung diseases, whereas plasmacytoid DCs play a crucial role in the defense against infections. Effects of inhaled corticosteroids (ICS) on airway DCs in smokers are unknown. METHODS: In this randomized, double-blind...
Autores principales: | Lommatzsch, Marek, Kraeft, Ulrike, Troebs, Laura, Garbe, Katharina, Bier, Andrea, Stoll, Paul, Klammt, Sebastian, Kuepper, Michael, Bratke, Kai, Virchow, Johann Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176093/ https://www.ncbi.nlm.nih.gov/pubmed/24168756 http://dx.doi.org/10.1186/1465-9921-14-114 |
Ejemplares similares
-
Impact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD
por: Stoll, Paul, et al.
Publicado: (2014) -
Imbalance of dendritic cell co-stimulation in COPD
por: Stoll, Paul, et al.
Publicado: (2015) -
Stage-dependent association of BDNF and TGF-β(1) with lung function in stable COPD
por: Stoll, Paul, et al.
Publicado: (2012) -
Adverse effects of salmeterol in asthma: a neuronal perspective
por: Lommatzsch, M, et al.
Publicado: (2009) -
COVID‐19 in a patient with severe asthma treated with Omalizumab
por: Lommatzsch, Marek, et al.
Publicado: (2020)